Loading the section…
The price of Biodesix, Inc. (BDSX) on October 9, 2026 is 26.02 USD, +1.52% on the day. Over 52 weeks the stock traded between 5.26 USD and 31.97 USD; the price now sits 78% of the way up that range. Over the past year the price changed by +235.74%. Market capitalization is 262.99 million USD, rank 16 among 23 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 2 November 2026 · Earnings calendar
Change over the period shown (line colour): +251.62 %
Biodesix, Inc. trades on Nasdaq under the ticker BDSX. The company belongs to the Health care sector. The trading history on this page starts on 28 October 2020.
Over the past 52 weeks BDSX has traded between 5.26 $ and 31.97 $. As of 9 October 2026 the price stood 77.72 % of the way from the 52-week low to the high.
Over one year BDSX shares rose 235.74 %; over six months they rose 98.17 %. Volatility over 90 days is 79.49 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 2.7, below the sector median of 4.0. Price to book is 28.8, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 25.68 | 26.64 | 25.63 | 26.02 | 46,700 |
| 8 October 2026 | 26.24 | 26.51 | 25.10 | 25.63 | 96,000 |
| 7 October 2026 | 27.50 | 27.78 | 26.07 | 26.42 | 57,600 |
| 6 October 2026 | 29.30 | 29.99 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:919 WEST DILLON ROAD, LOUISVILLE, CO, 80027, US
Biodesix, Inc. reported revenue of 96M $ and a net loss of 32M $ over the last four quarters. Net margin is −33.26 %. Revenue changed by +29.05 % year over year. Market capitalisation is 263M $.
BDSX has a return on equity of −349.95 %, below the sector median of −41.68 %. Return on assets is −33.77 %, below the sector median of −32.11 %. Operating margin is −25.95 %, above the sector median of −26.84 %.
| 245M |
| CAICaris Life Sciences, Inc. | 29.70 | +8.00 % | 141M |
| GRALGRAIL, Inc. | 140.58 | +6.01 % | 139M |
| CELCCelcuity Inc. | 67.94 | +0.10 % | 92M |
| CDNACareDx, Inc. | 63.67 | +2.36 % | 79M |
| 27.52 |
| 27.96 |
| 102,200 |
| 5 October 2026 | 27.72 | 30.00 | 26.53 | 29.06 | 181,200 |
| 2 October 2026 | 27.55 | 28.72 | 26.97 | 27.72 | 124,300 |
| 1 October 2026 | 29.45 | 29.70 | 26.33 | 27.33 | 178,900 |
| 30 September 2026 | 29.15 | 30.13 | 28.14 | 29.83 | 161,300 |
| 29 September 2026 | 30.57 | 31.21 | 28.56 | 29.14 | 142,600 |
| 28 September 2026 | 29.00 | 31.97 | 28.50 | 30.42 | 204,700 |
| 25 September 2026 | 29.47 | 30.17 | 28.48 | 29.10 | 98,300 |
| 24 September 2026 | 29.22 | 31.35 | 28.81 | 29.40 | 120,500 |
| 23 September 2026 | 27.99 | 29.49 | 27.65 | 29.29 | 69,000 |
| 22 September 2026 | 28.37 | 29.07 | 27.75 | 28.15 | 57,000 |
| 21 September 2026 | 29.36 | 29.99 | 27.56 | 28.43 | 122,400 |
| 18 September 2026 | 28.52 | 29.96 | 28.39 | 29.20 | 100,900 |
| 17 September 2026 | 28.99 | 29.42 | 28.52 | 28.81 | 60,800 |
| 16 September 2026 | 27.77 | 29.00 | 27.55 | 28.56 | 100,500 |
| 15 September 2026 | 27.40 | 28.00 | 26.42 | 27.70 | 69,400 |
| 14 September 2026 | 26.80 | 27.70 | 25.75 | 27.40 | 55,000 |